B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GSK3B

MOLECULAR TARGET

glycogen synthase kinase 3 beta

UniProt: P49841NCBI Gene: 293219 compounds

GSK3B (glycogen synthase kinase 3 beta) is targeted by 19 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GSK3B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1alsterpaullone3.0420
2kenpaullone2.8316
3indirubin1.956
4Apigenin 5,7,4'-trihydroxy-flavone,1.614
5Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.614
6Kaempferols1.393
7Quercetin1.393
8Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is1.393
9Lithium Chloride1.393
10chrysin1.102
11fisetin1.102
12ly2940021.102
13Sorafenib1.102
14egcg0.691
15Rutin0.691
16Ursolic Acid0.691
17Oleanolic Acid0.691
18sp6001250.691
19Zearalenone (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradec in-1,7(8H)-dione.0.691

About GSK3B as a Drug Target

GSK3B (glycogen synthase kinase 3 beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 19 compounds with documented GSK3B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GSK3B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.